Biotech CRO niche Affinity Bio Partners operates as a specialized mid-size CRO focusing on biologics, medical devices, and medical cannabis, presenting a clear cross‑selling opportunity to sponsors seeking niche clinical execution and regulatory support in these areas.

Regulatory & Compliance With services spanning SOX readiness, Medicare/ National Coverage Decision analysis, site contracting, and outsourcing governance, there is a strong upsell path to sponsors needing robust compliance, audit readiness, and accelerated regulatory timelines.

Strategic Partnerships Recent collaboration with Zelira Therapeutics to manage a multi-site trial indicates readiness for partnership-driven growth and potential for sponsored programs, investigator-initiated studies, and global site management services.

Expansion into Cannabis Active clinical study initiation in medical cannabis and experience with payer analytics suggests opportunities to expand as a preferred CRO for cannabis therapeutics trials and related reimbursement analyses.

Risk & Safety Niche Comprehensive drug safety, clinical quality auditing, and study start-up expertise position Affinity Bio Partners to service sponsors with high compliance demands and complex risk management across global trials.